Kodiak Sciences Inc. SEC filings KOD

Kodiak Sciences Inc. has 422 filings in SEC EDGAR's recent list, going back to Jul 28, 2009. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 28, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
10-K Annual report Mar 31, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 22, 2025 Dec 31, 2024
10-K Annual report Mar 27, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 23, 2024 Dec 31, 2023
10-K Annual report Mar 28, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 25, 2023 Dec 31, 2022
10-K Annual report Mar 28, 2023 Dec 31, 2022
10-K Annual report Mar 1, 2022 Dec 31, 2021
10-K Annual report Mar 1, 2021 Dec 31, 2020
10-K Annual report Mar 16, 2020 Dec 31, 2019
10-K Annual report Mar 27, 2019 Dec 31, 2018

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
KOD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Palo Alto, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1468748
Former names
Oligasis, LLC (until Jul 28, 2009)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.